CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 17 Issue: 1
Author(s): Laszlo Vecsei
Affiliation:
Export Options
About this article
Cite this article as:
Vecsei Laszlo , Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2018; 17 (1) . https://dx.doi.org/10.2174/187152731701180426141109
DOI https://dx.doi.org/10.2174/187152731701180426141109 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
37
2
1
2
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Implications of Prion Protein Biology
Current Neurovascular Research Opioid Use and Ventilator-Associated Pneumonia
Current Respiratory Medicine Reviews Pharmacological Approach of No-Reflow Phenomenon Related with Percutaneous Coronary Interventions
Cardiovascular & Hematological Agents in Medicinal Chemistry Acetylcholinesterase: Molecular Modeling with the Whole Toolkit
Current Topics in Medicinal Chemistry Editorial [Hot Topic: New Prospects for Treatment of Autoimmune Diseases (Executive Guest Editor: Alessandra Fierabracci)]
Current Pharmaceutical Design Monoamine Oxidase Inhibitors: Ten Years of Docking Studies
Current Topics in Medicinal Chemistry Amine Oxidase Inhibitors and Development of Neuroprotective Drugs
Current Neuropharmacology Uteroplacental Circulation and Fetal Vascular Function and Development
Current Vascular Pharmacology Molecule of the Month
Current Topics in Medicinal Chemistry Changing the Endocrine Dependence of Breast Cancer: Data and Hypotheses
Current Medicinal Chemistry Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive Review
Current Molecular Medicine Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions
Drug Metabolism Letters Experimental Strategies in Autoimmunity: Antagonists of Cytokines and their Receptors, Nanocarriers, Inhibitors of Immunoproteasome, Leukocyte Migration and Protein Kinases
Current Pharmaceutical Design In Silico Predictions of hERG Channel Blockers in Drug Discovery: From Ligand-Based and Target-Based Approaches to Systems Chemical Biology
Combinatorial Chemistry & High Throughput Screening Editorial [Hot topic: Endocannabinoid Receptor System (Guest Editor: Robyn A. Puffenbarger)]
CNS & Neurological Disorders - Drug Targets Editorial (Thematic Issue: Synthetic Androgen and New Psycho-Active Compounds (Smart Drugs) Abuse and Dependance. Neuropathological and Toxicological Findings, with an Approach Designed For the Future)
Current Neuropharmacology The Peripheral Nervous System and the Pathogenesis of Prion Diseases
Current Molecular Medicine May Patients with Alcohol Liver Disease Benefit from Herbal Medicines?
Reviews on Recent Clinical Trials Advances in Discovery of PDE10A Inhibitors for CNS-Related Disorders. Part 1: Overview of the Chemical and Biological Research
Current Drug Targets Conantokins: Peptide Antagonists of NMDA Receptors
Current Medicinal Chemistry